Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shouwujiangqi decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Zhangjiagang Traditional Chinese Medicine Hospital, which is affiliated with Nanjing University of Chinese Medicine. It is specifically indicated for the treatment of polycystic ovary syndrome (PCOS), particularly in patients presenting with the 'kidney deficiency and phlegm-stasis' pattern. The decoction is composed of several herbal ingredients, including processed *Polygonum multiflorum* (He Shou Wu), which are thought to work synergistically to regulate the hypothalamic-pituitary-ovarian (HPO) axis, reduce serum androgen levels, and improve insulin resistance. By addressing these underlying hormonal and metabolic disturbances, the therapy aims to restore regular ovulation and improve clinical symptoms such as menstrual irregularity and infertility associated with PCOS.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shouwujiangqi decoction.